Evidence map›Paper›PMID 25636036›Full record

ReviewInternational journal of molecular sciences2015

A time to kill: targeting apoptosis in cancer.

Jean L Koff, Sampath Ramachandiran, Leon Bernal-Mizrachi

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed.

  1. Article
  2. Programmed cell death in triple-negative breast cancer.Cellular & molecular biology letters · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Crosstalk between long noncoding RNA and microRNA in Cancer.Cellular oncology (Dordrecht, Netherlands) · 2023
    Review
  18. Review
  19. Article
  20. Tenglong Buzhong granules inhibits the growth of SW620 human colon cancer.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jean L KoffDepartment of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA. jkoff@emory.edu.
Sampath RamachandiranDepartment of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA. sramac2@emory.edu.
Leon Bernal-MizrachiDepartment of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA. lbernal@emory.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The process of apoptosis is essential for maintaining the physiologic balance between cell death and cell growth. This complex process is executed by two major pathways that participate in activating an executioner mechanism leading to chromatin disintegration and nuclear fragmentation. Dysregulation of these pathways often contributes to cancer development and resistance to cancer therapy. Here, we review the most recent discoveries in apoptosis regulation and possible mechanisms for resensitizing tumor cells to therapy.

Indexed as

ApoptosisAntineoplastic AgentsApoptosis Regulatory ProteinsCaspasesfas ReceptorHumansNeoplasmsReceptors, Tumor Necrosis FactorTNF-Related Apoptosis-Inducing LigandTumor Necrosis Factor-alphaAntineoplastic AgentsApoptosis Regulatory ProteinsCaspasesfas ReceptorReceptors, Tumor Necrosis FactorTNF-Related Apoptosis-Inducing LigandTumor Necrosis Factor-alpha

Identifiers

PMID25636036
PMCPMC4346874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.